Sonim Technologies INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
DNA X, Inc. reports Q1 2026 results following the divestiture of its legacy hardware business and transition to an AI-driven cryptocurrency trading platform.
NASDAQ
Sonim Technologies reports increased quarterly net loss and significant cash burn, raising substantial doubt about its ability to continue as a going concern, while pursuing an asset sale and strategic alternatives.
NASDAQ
Sonim Technologies reported an increased net loss for Q2 2025 and is pursuing a strategic asset sale and reverse merger to maximize stockholder value.
NASDAQ
Sonim Technologies' Q1 2025 results show a slight revenue decrease but improved gross profit due to customer allowance expirations, alongside strategic expansion and new product launches.
NASDAQ
Sonim Technologies experienced a significant revenue decrease in Q3 2024 due to a strategic shift away from white-label products, while launching new rugged devices and hotspots.
NASDAQ
Sonim Technologies experienced a significant revenue decrease in Q2 2024 due to a strategic shift away from white-label products, while preparing for new product launches in the second half of the year.
NASDAQ
Sonim Technologies experienced a revenue decrease in Q1 2024 due to a transition away from white-label products, while preparing for new product launches in the second half of the year.